Cargando…

SARS-CoV-2 Doggybone DNA Vaccine Produces Cross-Variant Neutralizing Antibodies and Is Protective in a COVID-19 Animal Model

To combat the COVID-19 pandemic, an assortment of vaccines has been developed. Nucleic acid vaccines have the advantage of rapid production, as they only require a viral antigen sequence and can readily be modified to detected viral mutations. Doggybone™ DNA vaccines targeting the spike protein of S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mucker, Eric M., Brocato, Rebecca L., Principe, Lucia M., Kim, Robert K., Zeng, Xiankun, Smith, Jeffrey M., Kwilas, Steven A., Kim, Sungwon, Horton, Helen, Caproni, Lisa, Hooper, Jay W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317096/ https://www.ncbi.nlm.nih.gov/pubmed/35891268 http://dx.doi.org/10.3390/vaccines10071104

Ejemplares similares

Protective efficacy of a SARS-CoV-2 DNA vaccine in wild-type and immunosuppressed Syrian hamsters
por: Brocato, Rebecca L., et al.
Publicado: (2021)

Anti-HFRS Human IgG Produced in Transchromosomic Bovines Has Potent Hantavirus Neutralizing Activity and Is Protective in Animal Models
por: Perley, Casey C., et al.
Publicado: (2020)

Novel synthetic plasmid and Doggybone™ DNA vaccines induce neutralizing antibodies and provide protection from lethal influenza challenge in mice
por: Scott, Veronica L, et al.
Publicado: (2015)

Safe and stable generation of induced pluripotent stem cells using doggybone DNA vectors
por: Thornton, Christopher D., et al.
Publicado: (2021)

CAR T Cell Generation by piggyBac Transposition from Linear Doggybone DNA Vectors Requires Transposon DNA-Flanking Regions
por: Bishop, David C., et al.
Publicado: (2020)

Animal Models for the Study of Rodent-Borne Hemorrhagic Fever Viruses: Arenaviruses and Hantaviruses
por: Golden, Joseph W., et al.
Publicado: (2015)

Corrigendum to “Animal Models for the Study of Rodent-Borne Hemorrhagic Fever Viruses: Arenaviruses and Hantaviruses”
por: Golden, Joseph W., et al.
Publicado: (2015)

Antigenic mapping and functional characterization of human New World hantavirus neutralizing antibodies
por: Engdahl, Taylor B, et al.
Publicado: (2023)

Three asymptomatic animal infection models of hemorrhagic fever with renal syndrome caused by hantaviruses
por: Perley, Casey C., et al.
Publicado: (2019)

Linear doggybone DNA vaccine induces similar immunological responses to conventional plasmid DNA independently of immune recognition by TLR9 in a pre-clinical model
por: Allen, Alex, et al.
Publicado: (2018)

An attenuated Machupo virus with a disrupted L-segment intergenic region protects guinea pigs against lethal Guanarito virus infection
por: Golden, Joseph W., et al.
Publicado: (2017)

Lipid Nanoparticle Formulation Increases Efficiency of DNA-Vectored Vaccines/Immunoprophylaxis in Animals Including Transchromosomic Bovines
por: Mucker, Eric M., et al.
Publicado: (2020)

Disruption of Adaptive Immunity Enhances Disease in SARS-CoV-2-Infected Syrian Hamsters
por: Brocato, Rebecca L., et al.
Publicado: (2020)

A Hantavirus Pulmonary Syndrome (HPS) DNA Vaccine Delivered Using a Spring-powered Jet Injector Elicits a Potent Neutralizing Antibody Response in Rabbits and Nonhuman Primates
por: Kwilas, Steve, et al.
Publicado: (2014)

Antiviral Biologic Produced in DNA Vaccine/Goose Platform Protects Hamsters Against Hantavirus Pulmonary Syndrome When Administered Post-exposure
por: Haese, Nicole, et al.
Publicado: (2015)

Lipid nanoparticle delivery of unmodified mRNAs encoding multiple monoclonal antibodies targeting poxviruses in rabbits
por: Mucker, Eric M., et al.
Publicado: (2022)

Progress on the Prevention and Treatment of Hantavirus Disease
por: Brocato, Rebecca L., et al.
Publicado: (2019)

Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease
por: Golden, Joseph W., et al.
Publicado: (2021)

DNA Vaccine-Generated Duck Polyclonal Antibodies as a Postexposure Prophylactic to Prevent Hantavirus Pulmonary Syndrome (HPS)
por: Brocato, Rebecca, et al.
Publicado: (2012)

Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease
por: Golden, Joseph W., et al.
Publicado: (2020)

Intranasal monkeypox marmoset model: Prophylactic antibody treatment provides benefit against severe monkeypox virus disease
por: Mucker, Eric M., et al.
Publicado: (2018)

Humoral immunogenicity of a Coronavirus Disease 2019 (COVID-19) DNA vaccine in rhesus macaques (Macaca mulatta) delivered using needle-free jet injection
por: Jay, Alexandra, et al.
Publicado: (2023)

Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2
por: Ji, Yun, et al.
Publicado: (2022)

Human Polyclonal Antibodies Produced through DNA Vaccination of Transchromosomal Cattle Provide Mice with Post-Exposure Protection against Lethal Zaire and Sudan Ebolaviruses
por: Bounds, Callie E., et al.
Publicado: (2015)

Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage libraries
por: Yuan, Tom Z., et al.
Publicado: (2021)

Side-by-Side Comparison of Gene-Based Smallpox Vaccine with MVA in Nonhuman Primates
por: Golden, Joseph W., et al.
Publicado: (2012)

VOC 202012/01 Variant Is Effectively Neutralized by Antibodies Produced by Patients Infected before Its Diffusion in Italy
por: Rondinone, Valeria, et al.
Publicado: (2021)

Previous Infection Combined with Vaccination Produces Neutralizing Antibodies with Potency against SARS-CoV-2 Variants
por: Ibarrondo, F. Javier, et al.
Publicado: (2021)

Neutralization of Animal Viruses
por: Mandel, Benjamin
Publicado: (1978)

Evaluation of a panel of therapeutic antibody clinical candidates for efficacy against SARS-CoV-2 in Syrian hamsters
por: Cong, Yu, et al.
Publicado: (2023)

Ten emerging SARS-CoV-2 spike variants exhibit variable infectivity, animal tropism, and antibody neutralization
por: Zhang, Li, et al.
Publicado: (2021)

Characterization of Neutralizing Human Anti-Tetanus Monoclonal Antibodies Produced by Stable Cell Lines
por: Manieri, Tania Maria, et al.
Publicado: (2022)

Development of Antibody-Fragment–Producing Rice for Neutralization of Human Norovirus
por: Sasou, Ai, et al.
Publicado: (2021)

Depletion of Alveolar Macrophages Does Not Prevent Hantavirus Disease Pathogenesis in Golden Syrian Hamsters
por: Hammerbeck, Christopher D., et al.
Publicado: (2016)

Comparison of VSV Pseudovirus and Focus Reduction Neutralization Assays for Measurement of Anti-Andes orthohantavirus Neutralizing Antibodies in Patient Samples
por: Vial, Cecilia, et al.
Publicado: (2020)

Maternal Broadly Neutralizing Antibodies Can Select for Neutralization-Resistant, Infant-Transmitted/Founder HIV Variants
por: Martinez, David R., et al.
Publicado: (2020)

Producing animation
por: Winder, Catherine, et al.
Publicado: (2001)

Producing animation
por: Winder, Catherine, et al.
Publicado: (2011)

A recombinant subunit vaccine candidate produced in plants elicits neutralizing antibodies against SARS-CoV-2 variants in macaques
por: Khorattanakulchai, Narach, et al.
Publicado: (2022)

A neutralizing bispecific single-chain antibody against SARS-CoV-2 Omicron variant produced based on CR3022
por: Yu, Kaikai, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8hpr0uq5fr8avb3odn565263b8